Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
COVID-19
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Specifically, the warning states that reports of adverse events after use of the vaccine under emergency use authorization (EUA) suggest increased risks of myocarditis and pericarditis, particularly from zero through seven days following vaccination.
March 14, 2023
Chicago man indicted for COVID-19 testing fraud
A Chicago lab that he co-owned obtained more then $83 million from the HRSA Uninsured Program as payment for COVID-19 tests purportedly performed by the laboratory, a U.S. Attorney's Office said.
March 14, 2023
Virufy nabs BARDA contract to develop cough- and speech-based COVID-19 detection technology
The project supports the firm’s aim to research and develop COVID-19 screening tools using artificial intelligence (AI)/machine learning (ML) technology.
March 8, 2023
COVID-19 leads to increased chest pain long after infection
In an ongoing effort to quantify long COVID’s impacts, nearly 150,000 patients were studied for cardiovascular symptoms following a COVID-19 infection.
March 6, 2023
Artificial intelligence tool identifies current drugs for future pandemics
Researchers have created an algorithmic tool that calculates how to effectively repurpose current drugs to combat COVID-19 and future pandemics.
March 6, 2023
COVID-19 vaccine development: Public funding yielded private profits
A BMJ study calculated U.S. public investments in pre-pandemic COVID-19 vaccine development and recommended policy reforms to maximize public health benefits.
March 1, 2023
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Collaborative research helps long-COVID patients recover
An NIH initiative called Researching COVID to Enhance Recovery (RECOVER) joins patients with researchers to better understand and treat long COVID.
March 3, 2023
Immune-response test in study detects COVID-19 with near-perfect accuracy
A test that monitors the body’s molecular response to the SARS‑CoV‑2 virus can diagnose even asymptomatic patients with near-perfect accuracy, the researchers said.
March 1, 2023
NanoSpot.ai launches AI-based SARS-CoV-2 antibody test
The test uses an agglutination-based method combined with an artificial intelligence (AI)-enabled mobile application to deliver semi-quantitative antibody test results at the point of care.
February 28, 2023
University of Michigan breath analysis technology holds potential for COVID-19 detection
A diagnostic study indicates that a portable breath-based volatile organic compound monitor may have potential for COVID-19 detection.
March 1, 2023
Mologic receives FDA EUA for at-home SARS-CoV-2 antigen test, eyes additional respiratory diseases
The development of the rapid antigen test was funded under an $11.8 million contract through the US National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative.
February 27, 2023
FDA authorizes Lucira Health OTC test, the first to detect influenza and COVID-19 viruses
In people with symptoms, the Lucira COVID-19 & Flu Test correctly identified 99.3% of negative and 90.1% of positive influenza A samples; 100% of negative and 88.3% of positive COVID-19 samples; and 99.9% of negative influenza B samples, the FDA said.
February 24, 2023
Page 1 of 29
Next Page
